Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis-Reference-Cited by-同舟云学术

Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis

Published:2006-11-29 Issue:7 Volume:245 Page:1045-1048
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Jorge Rodrigo,Costa Rogério A.,Calucci Daniela,Scott Ingrid U.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-006-0468-2.pdf

Reference9 articles.

1. Costa RA, Jorge R, Calucci D, Cardillo JA, Melo Jr LAS, Scott IU (2006) Intravitreal bevacizumab (Avastin) for choroidal neovascularization caused by AMD (IBeNA Study): results of a phase I dose-escalation study. Invest Ophthalmol Vis Sci 47:4569–4578

2. Engelbrecht NE, Aaberg TM Jr, Sung J, Lewis ML (2002) Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol 120(3):320–324

3. Gass JDM (1997) Retinal capillary diseases. In: Gass JDM (eds) Stereoscopic atlas of macular diseases: diagnosis and treatment, 4th edn. CV Mosby, St. Louis, Missouri, pp 494–515

4. Potter MJ, Szabo SM, Chan EY, Morris AHC (2002) Photodynamic therapy of a subretinal neovascular membrane in type 2A idiopathic juxtafoveolar retinal telangiectasis. Am J Ophthalmol 133(1):149–151

5. Rosenfeld PJ, Moshfeghi AA, Puliafito CA (2005) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36(4):331–335

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Idiopathic Macular Telangiectasia;Albert and Jakobiec's Principles and Practice of Ophthalmology;2022

2. Real-world outcomes of intravitreal anti-vascular endothelial growth factor monotherapy in proliferative type 2 macular telangiectasia;Graefe's Archive for Clinical and Experimental Ophthalmology;2020-11-17

3. Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2;British Journal of Ophthalmology;2020-06-08

4. Subretinal Neovascularization Associated with Idiopathic Juxtafoveal Telangiectasia;Choroidal Neovascularization;2020

5. Idiopathic Macular Telangiectasia;Albert and Jakobiec's Principles and Practice of Ophthalmology;2020